Skip to main content

Advertisement

SpringerLink
Log in

Reactive arthritis: update 2018

  • Review Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

At this time, reactive arthritis (ReA) is considered to be part of the spectrum of the spondyloarthritis, previously known as Reiter’s syndrome, and refers to an infection induced systemic illness, characterized by a sterile synovitis occurring in a genetically predisposed individual, secondary to an infection localized in a distant organ/system, but also accompanied with multiple extra articular manifestations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Keynan Y, Rimar D (2008) Reactive arthritis—the appropriate name. Isr Med Assoc J 10(4):256–258

    PubMed  Google Scholar 

  2. Panush R, Wallace D, Dorff R, Engleman E (2007) Retraction of the suggestion to use the term «Reiter’s syndrome» sixty-five years later. Arthritis Rheum 56(2):693–694. https://doi.org/10.1002/art.22374

    Article  PubMed  Google Scholar 

  3. Stavropoulos P, Soura E, Kanelleas A, Katsambas A, Antoniou C (2015) Reactive arthritis. J Eur Acad Dermatology Venereol 29(3):415–424. https://doi.org/10.1111/jdv.12741

    Article  CAS  Google Scholar 

  4. Hannu T (2011) Reactive arthritis. Best Pract Res Clin Rheumatol 25(3):347–357. https://doi.org/10.1016/j.berh.2011.01.018

    Article  PubMed  Google Scholar 

  5. Colmegna I, Cuchacovich R, Espinoza L (2004) HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations. Clin Microbiol Rev 17(2):348–369. https://doi.org/10.1128/CMR.17.2.348

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Gupta R, Misra R (2016) Microbe-triggered arthropathies: reactive arthritis and beyond. Int J Rheum Dis 19(5):437–439. https://doi.org/10.1111/1756-185X.12920

    Article  PubMed  Google Scholar 

  7. Lopez Férez F, García Novo E (1986) Tratados hipocráticos. (eds) Gredos, Madrid, España

  8. Allison D (1980) Christopher Columbus: first case of Reiter’S disease in the old world? Lancet 316(8207):1309. https://doi.org/10.1016/S0140-6736(80)92381-8

    Article  Google Scholar 

  9. Carter J, Hudson A (2009) Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin N Am 35(1):21–44. https://doi.org/10.1016/j.rdc.2009.03.010

    Article  Google Scholar 

  10. Manasson J, Shen N, García H, Ubeda C, Iraheta I, Heguy A, Von Feldt J, Espinoza L, García Kutzbach A, Segal L, Ogdie A, Clemente J, Sher J (2017) Gut microbiota perturbations in reactive arthritis and post-infectious Spondyloarthritis arthritis. Rheum. https://doi.org/10.1002/art.40359 [Epub ahed of print]

  11. Ehrenfeld M (2010) Geoepidemiology: the environment and spondyloarthropathies. Autoimmun Rev 9(5):A325–A329. https://doi.org/10.1016/j.autrev.2009.11.012

    Article  PubMed  Google Scholar 

  12. Szamocki S, Martyn-hemphill C, Green J (2016) Reactive arthritis: can’t see, can’t pee, can’t climb a tree. Trends Urol Men’s Heal 7(1):17–20. https://doi.org/10.1002/tre.501

    Article  Google Scholar 

  13. García-Kutzbach A, Montenegro A, Iraheta I, Bará C, Saénz R (2011) Epidemiology of spondyloarthropathies in Central America. Am J Med Sci 341(4):295–297. https://doi.org/10.1097/MAJ.0b013e31820f8cf1

    Article  PubMed  Google Scholar 

  14. Brewerton D, Hart F, Nicholls A, Caffrey M, James D, Sturrock R (1973) Ankylosing spondylitis and HlA 27. Lancet 301(7809):904–907. https://doi.org/10.1016/S0140-6736(73)91360-3

    Article  Google Scholar 

  15. Schlosstein L, Terasaki P, Bluestone R, Pearson C (1973) High association of an HLA antigen, W27 with ankylosing spondylitis. N Engl J Med 288(14):704–705. https://doi.org/10.1056/NEJM197304052881403

    Article  CAS  PubMed  Google Scholar 

  16. Vazquez-Torres A, Vallance B, Bergman M, Finlay B, Cookson B, Jones-Carson J et al (2004) Toll-like receptor 4 dependence of innate and adaptive immunity to salmonella: importance of the Kupffer cell network. J Immunol 172(10):6202–6208. https://doi.org/10.4049/jimmunol.172.10.6202

    Article  CAS  PubMed  Google Scholar 

  17. Reveille JD (2014) An update on the contribution of the MHC to as susceptibility. Clin Rheumatol 33(6):749–757. https://doi.org/10.1007/s10067-014-2662-7

    Article  PubMed  PubMed Central  Google Scholar 

  18. Tsui F, Xi N, Rohekar S, Riarh R, Bilotta R, Tsui H et al (2008) Toll-like receptor 2 variants are associated with acute reactive arthritis. Arthritis Rheum 58(11):3436–3438. https://doi.org/10.1002/art.23967

    Article  CAS  PubMed  Google Scholar 

  19. Rihl M, Klos A, Köhler L, Kuipers J (2006) Reactive arthritis. Best Pract Res Clin Rheumatol 20(6):1119–1137. https://doi.org/10.1016/j.berh.2006.08.008

    Article  PubMed  Google Scholar 

  20. Denison H, Curtis E, Clynes M, Bromhead C, Dennison E, Grainger R (2016) The incidence of sexually acquired reactive arthritis: a systematic literature review. Clin Rheumatol 35(11):2639–2648. https://doi.org/10.1007/s10067-016-3364-0

    Article  PubMed  PubMed Central  Google Scholar 

  21. Asquith M, Rosenbaum J (2016) The interaction between host genetics and the microbiome in the pathogenesis of spondyloarthropathies. Curr Opin Rheumatol 28(4):405–412. https://doi.org/10.1097/BOR.0000000000000299

    Article  CAS  PubMed  Google Scholar 

  22. Reveille JD (2012) Genetics of spondyloarthritis—beyond the MHC. Nat Rev Rheumatol 8(5):296–304. https://doi.org/10.1038/nrrheum.2012.41

    Article  CAS  PubMed  Google Scholar 

  23. Pope J, Krizova A, Garg A, Thiessen-Philbrook H, Ouimet J (2007) Campylobacter reactive arthritis: a systematic review. Semin Arthritis Rheum 37(1):48–55. https://doi.org/10.1016/j.semarthrit.2006.12.006

    Article  PubMed  PubMed Central  Google Scholar 

  24. Zeidler H, Hudson A (2016) Coinfection of chlamydiae and other bacteria in reactive arthritis and spondyloarthritis: need for future research. Microorganisms 4(3):30. https://doi.org/10.3390/microorganisms4030030

    Article  PubMed Central  Google Scholar 

  25. Carter J, Inman R (2011) Chlamydia-induced reactive arthritis: hidden in plain sight? Best Pract Res Clin Rheumatol 25(3):359–374. https://doi.org/10.1016/j.berh.2011.05.001

    Article  PubMed  Google Scholar 

  26. Gaston J (2005) Shigella induced reactive arthritis. Ann Rheum Dis 64(4):517–518. https://doi.org/10.1136/ard.2004.030395

    Article  PubMed  PubMed Central  Google Scholar 

  27. Cargnelutti E, Di Genaro M (2013) Reactive arthritis: from clinical features to pathogenesis. Int J Clin Med 4(12):20–30. https://doi.org/10.4236/ijcm.2013.412A2004

    Article  Google Scholar 

  28. Garcia H, Azan A, Iraheta I, Von Feldt J, Espinoza L, Manasson J, Scher J, García Kutzbach A (2017) Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-up. Clin Rheumatol. https://doi.org/10.1007/s10067-017-3911.3 [Epub ahed of print]

  29. Van de Wiele T, Van Praet J, Marzorati M, Drennan M, Elewaut D (2016) How the microbiota shapes rheumatic diseases. Nat Rev Rheumatol 12(7):398–411. https://doi.org/10.1038/nrrheum.2016.85

    Article  PubMed  Google Scholar 

  30. Caminer A, Haberman R, Scher J (2017) Human microbiome, infections, and rheumatic disease. Clin Rheumatol 36(12):2645–2653. https://doi.org/10.1007/s10067-017-3875-3

    Article  PubMed  Google Scholar 

  31. Brown J, Hazen S (2015) The gut microbial endocrine organ: bacterially-derived signals driving cardiometabolic diseases. Annu Rev Med 66(1):343–359. https://doi.org/10.1146/annurev-med-060513-093205

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Eckburg P, Bik E, Bernstein C, Purdom E, Dethlefsen L, Sargent M, Gill S, Nelson K, Relman D (2005) Diversity of the human intestinal microbial flora. Science 308(5728):1635–1638. https://doi.org/10.1126/science.1110591

    Article  PubMed  PubMed Central  Google Scholar 

  33. Blaser M, Bork P, Fraser C, Knight R, Wang J (2013) The microbiome explored: recent insights and future challenges. Nat Rev Microbiol 11(3):213–217. https://doi.org/10.1038/nrmicro2973

    Article  CAS  PubMed  Google Scholar 

  34. Catrina A, Deane K, Scher J (2016) Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis. Rheumatology 55(3):391–402. https://doi.org/10.1093/rheumatology/keu469

    CAS  PubMed  Google Scholar 

  35. Wendling D, Prati C (2017) Spondyloarthritis: an expanding cast of cellular actors. Jt bone Spine:1–3. https://doi.org/10.1016/j.jbspin.2017.05

  36. Ericsson A, Hagan C, Davis D, Franklin C (2014) Segmented filamentous bacteria: commensal microbes with potential effects on research. Comp Med 64(2):90–98

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Ji B, Nielsen J (2015) New insight into the gut microbiome through metagenomics. Adv Genomics Genet 5:77–91. https://doi.org/10.2147/AGG.S57215

    CAS  Google Scholar 

  38. Ivanov I, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U et al (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139(3):485–498. https://doi.org/10.1016/j.cell.2009.09.033

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Miossec P (2017) Update on interleukin-17: a role in the pathogenesis of inflammatory arthritis and implication for clinical practice. RMD 3(1):e000284. https://doi.org/10.1136/rmdopen-2016-000284

    Article  Google Scholar 

  40. Riente L, Sedie A, Filippucci E, Iagnocco A, Meenagh G, Grassi W, Valesini G, Bombardieri S (2007) Ultrasound imaging for the rheumatologist IX. Ultrasound imaging in spondyloarthritis. Clin Exp Rheumatol 25(3):349–353

    CAS  PubMed  Google Scholar 

  41. Colmegna I, Espinoza L (2005) Recent advances in reactive arthritis. Curr Rheumatol Rep 7(3):201–207. https://doi.org/10.1007/s11926-996-0040-4

    Article  PubMed  Google Scholar 

  42. Allen-Vercoe E, Reid G, Viner N, Gloor G, Hota S, Kim P, Lee C, O’Doherty K, Vanner S, Weewe S, Petrof E (2012) A Canadian working group report on fecal microbial therapy: microbial ecosystems therapeutics. Can J Gastroenterol 26(7):457–462. https://doi.org/10.1155/2012/213828

Download references

Author information

Authors and Affiliations

  1. AGAR, FM - UFM. Asociación Guatemalteca Anti-enfermedades Reumáticas, Facultad de Medicina, Universidad Francisco Marroquín, Guatemala City, CA, Guatemala

    A. García-Kutzbach, J. Chacón-Súchite, H. García-Ferrer & I. Iraheta

Authors
  1. A. García-Kutzbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Chacón-Súchite
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. García-Ferrer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. Iraheta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. García-Kutzbach.

Ethics declarations

Conflicts of interest

Abraham Garcia-Kutzbach: serve as Principal Investigator for clinical studies of Merck, Abbie, Novartis, and Janssen

Helga Garcia: Medical Scientific Liaison for Novartis Pharma Central America and Caribbean

Jose A. Chacon and Isa Iraheta do not report conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

García-Kutzbach, A., Chacón-Súchite, J., García-Ferrer, H. et al. Reactive arthritis: update 2018. Clin Rheumatol 37, 869–874 (2018). https://doi.org/10.1007/s10067-018-4022-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-018-4022-5

Keywords

Search

Navigation